Literature DB >> 8961274

Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1.

R H Zetterström1, L Solomin, T Mitsiadis, L Olson, T Perlmann.   

Abstract

NGFI-B, Nurr1, and Nor1 are three closely related orphan members of the steroid/thyroid hormone receptor superfamily. These receptors can bind to DNA as monomers and exhibit constitutive transcriptional activity. Moreover, two of the receptors, NGFI-B and Nurr1, have previously been shown to form heterodimers with the retinoid X receptor (RXR). Such heterodimers as well as complexes formed between RXR and the all-trans retinoic acid receptor bind to DNA response elements composed of direct repeats spaced by five nucleotides (DR5). However, whereas retinoic acid receptor can inhibit ligand-dependent RXR activation, NGFI-B and Nurr1 allow efficient RXR activation through DR5 elements and thus define a distinct pathway for vitamin A signaling. In this study we demonstrate that the most recently identified member of the subfamily, Nor1, shows similar monomer DNA-binding and constitutive transactivation properties as NGFI-B and Nurr1. In contrast, however, Nor1 is unable to promote RXR signaling due to its inability to form heterodimers with RXR. To begin to understand the physiological implications of these functional differences we used in situ hybridization to compare the distribution of Nor1, NGFI-B, and Nurr1 messenger RNAs during different developmental stages. The receptors are expressed in both distinct and overlapping patterns, predominantly in the central nervous system. Notably, Nurr1 is expressed in the prenatal ventral midbrain in a region that gives rise to dopaminergic neurons. Nor1 is also expressed during embryonic development, and all three receptors show a complex distribution in the postnatal brain. Furthermore, Nor1 colocalizes with NGFI-B in the adrenal glands and thymus, two tissues in which NGFI-B has been suggested to be functionally important. These data may indicate redundancy between members of the NGFI-B/Nurr1/Nor1 subfamily and could explain why no phenotypic disturbances have yet been found in mice in which the NGFI-B gene has been inactivated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961274     DOI: 10.1210/mend.10.12.8961274

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  58 in total

1.  NR4A Orphan Nuclear Receptors in Cardiovascular Biology.

Authors:  Yue Zhao; Dennis Bruemmer
Journal:  Drug Discov Today Dis Mech       Date:  2009

2.  The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation.

Authors:  Takashi Nomiyama; Takafumi Nakamachi; Florence Gizard; Elizabeth B Heywood; Karrie L Jones; Naganari Ohkura; Ryuzo Kawamori; Orla M Conneely; Dennis Bruemmer
Journal:  J Biol Chem       Date:  2006-08-31       Impact factor: 5.157

3.  Genetic program of neuronal differentiation and growth induced by specific activation of NMDA receptors.

Authors:  Cristina A Ghiani; Luis Beltran-Parrazal; Daniel M Sforza; Jemily S Malvar; Akop Seksenyan; Ruth Cole; Desmond J Smith; Andrew Charles; Pedro A Ferchmin; Jean de Vellis
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

4.  Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer.

Authors:  Vijaykumar R Holla; Hong Wu; Qiong Shi; David G Menter; Raymond N DuBois
Journal:  J Biol Chem       Date:  2011-07-10       Impact factor: 5.157

Review 5.  Adopting new orphans into the family of metabolic regulators.

Authors:  Sarah Hummasti; Peter Tontonoz
Journal:  Mol Endocrinol       Date:  2008-02-07

6.  Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.

Authors:  Asa Wallen-Mackenzie; Alexander Mata de Urquiza; Susanna Petersson; Francisco J Rodriguez; Stina Friling; Joseph Wagner; Peter Ordentlich; Johan Lengqvist; Richard A Heyman; Ernest Arenas; Thomas Perlmann
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

7.  Nuclear receptor 4A (NR4A) family - orphans no more.

Authors:  Stephen Safe; Un-Ho Jin; Benjamin Morpurgo; Ala Abudayyeh; Mandip Singh; Ronald B Tjalkens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-23       Impact factor: 4.292

Review 8.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

9.  Differentiation and transcription factor gene therapy in experimental parkinson's disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration.

Authors:  A Hurtado-Lorenzo; E Millan; V Gonzalez-Nicolini; D Suwelack; M G Castro; P R Lowenstein
Journal:  Mol Ther       Date:  2004-09       Impact factor: 11.454

10.  Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease.

Authors:  Eva Hedlund; Jan Pruszak; Thomas Lardaro; Wesley Ludwig; Angel Viñuela; Kwang-Soo Kim; Ole Isacson
Journal:  Stem Cells       Date:  2008-04-03       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.